Twelve outstanding BC Cancer researchers have received significant grants totalling over $4.6 million from the federal government. The funding provided by the Canadian Institutes of Health Research (CIHR) will allow them and their teams to pursue research breakthroughs in cancer, leading to a better understanding of cancer and improved outcomes. The below are the recipients from the 2019 Fall Project Grant results. 

Ryan Brinkman & Andrew Weng: Machine Learning for Flow Cytometry Clinical Data and Trial Analysis

$317,475

Xiaoyan Jiang: Targeting a novel miR-185/PAK6 axis to overcome drug-resistance in human leukemia

$902,700

$688,500

Brad Nelson: Mechanisms of B cell-mediated immunity in human cancer

$1,193,400

Robert Olson, Alison Allan, David Palma, Stuart Peacock, & Scott Tyldesley: A phase III randomized controlled trial and economic evaluation of Stereotactic Ablative Radiotherapy (SABR) for Comprehensive treatment of OligoMETastatic (1-3 metastases) cancer: SABR-COMET-3

$699,380

Ly Vu: mRNA decay and translational regulation by RNA deadenylation in Myeloid Leukemia

$872,100

This round, CIHR invested approximately $275 million for 385 research grants across Canada. CIHR invests approximately $1 billion annually to support science, research and innovation.  The multi-year grants are awarded to investigators at any stage in their career as they conduct research projects that cover the full range of health research topics. Grant recipients are leaders in their fields tackling pressing health issues that matter to Canadians.   

Congratulations to these recipients for their efforts towards reducing the burden of cancer for all British Columbians.